With this analysis, they can deduce the aggressiveness of adenocarcinoma and leiomyosarcoma uterine tumors. The starting point was a previous study in which the same tools...
Pharma Mar has other programs in the clinical development phase for various types of solid tumors: lurbinectedin, and ecubectedin. Headquartered in Madrid, the group has subsidiaries...